These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39057073)

  • 1. Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer.
    Jeong Y; Chu J; Kang J; Baek S; Lee JH; Jung DS; Kim WW; Kim YR; Kang J; Do IG
    Curr Issues Mol Biol; 2024 Jul; 46(7):7291-7302. PubMed ID: 39057073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.
    Raghu A; Raghu A; Wise JF
    JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
    Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
    JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of an interactive artificial intelligence platform to predict postoperative ambulatory status for patients with metastatic spinal disease: a multicenter analysis.
    Cui Y; Shi X; Qin Y; Wang Q; Cao X; Che X; Pan Y; Wang B; Lei M; Liu Y
    Int J Surg; 2024 May; 110(5):2738-2756. PubMed ID: 38376838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a machine learning-based predictive model for assessing the 90-day prognostic outcome of patients with spontaneous intracerebral hemorrhage.
    Geng Z; Yang C; Zhao Z; Yan Y; Guo T; Liu C; Wu A; Wu X; Wei L; Tian Y; Hu P; Wang K
    J Transl Med; 2024 Mar; 22(1):236. PubMed ID: 38439097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary.
    Zhang Y; Xia L; Ma D; Wu J; Xu X; Xu Y
    Front Oncol; 2021; 11():722808. PubMed ID: 34692498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a web-based artificial intelligence prediction model to assess massive intraoperative blood loss for metastatic spinal disease using machine learning techniques.
    Shi X; Cui Y; Wang S; Pan Y; Wang B; Lei M
    Spine J; 2024 Jan; 24(1):146-160. PubMed ID: 37704048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
    Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
    Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Machine Learning Method to Trace Cancer Primary Lesion Using Microarray-Based Gene Expression Data.
    Lu Q; Chen F; Li Q; Chen L; Tong L; Tian G; Zhou X
    Front Oncol; 2022; 12():832567. PubMed ID: 35530331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration and verification a 13-gene diagnostic framework for ulcerative colitis across multiple platforms via machine learning algorithms.
    Wang J; Li L; Chen P; He C; Niu X
    Sci Rep; 2024 Jul; 14(1):15009. PubMed ID: 38951638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type.
    Abraham J; Heimberger AB; Marshall J; Heath E; Drabick J; Helmstetter A; Xiu J; Magee D; Stafford P; Nabhan C; Antani S; Johnston C; Oberley M; Korn WM; Spetzler D
    Transl Oncol; 2021 Mar; 14(3):101016. PubMed ID: 33465745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
    Ruan J; Xu S; Chen R; Qu W; Li Q; Ye C; Wu W; Jiang Q; Yan F; Shen E; Chu Q; Jia Y; Zhang X; Fu W; Chen J; Timko MP; Zhao P; Fan L; Shen Y
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36259363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
    Lorkowski SW; Dermawan JK; Rubin BP
    Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.
    Capurro N; Pastore VP; Touijer L; Odone F; Cozzani E; Gasparini G; Parodi A
    Br J Dermatol; 2024 Jul; 191(2):261-266. PubMed ID: 38581445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin.
    Michuda J; Breschi A; Kapilivsky J; Manghnani K; McCarter C; Hockenberry AJ; Mineo B; Igartua C; Dudley JT; Stumpe MC; Beaubier N; Shirazi M; Jones R; Morency E; Blackwell K; Guinney J; Beauchamp KA; Taxter T
    Mol Diagn Ther; 2023 Jul; 27(4):499-511. PubMed ID: 37099070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.